Immune Reconstitution and Need for Booster Vaccinations Among Non‐Transplant Childhood Cancer Survivors: A Single‐Center Experience
This study suggests that most CCS are ready for re-immunization with inactivated vaccines by 6 months of therapy and underscores the need for boosters to optimize protection against vaccine-preventable infections. Future studies are needed to inform consensus guidelines adapted to patient age, underlying cancer diagnosis, and treatment intensity.
Authors
- Julie Voeller (ORCID: https://orcid.org/0000-0001-7811-513X)
- Jonathan D. Crews
- Nadia Cheek
- Eisei Shin
- Hongxing Han
- Araceli Elizalde
- Kenneth J. Nobleza (ORCID: https://orcid.org/0009-0009-0708-7245)
Institutions
- Baylor College of Medicine (US)
- Christus Health (US)
- Atlanta Allergy and Asthma Clinic (US)
- CHRISTUS Transplant Institute (US)
- University of the Incarnate Word (US)
Publication Details
- Journal
- Cancer Reports
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/cnr2.70326
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00